Clinical Trial Update: Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating the use of statins for primary prevention of heart failure in patients receiving anthracycline therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiotoxicity
• Heart Failure

Drugs mentioned

• Statins

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer, Heart Failure | Phase 2 | Status: UNKNOWN